MRI pattern in asymptomatic natalizumab-associated PML. (Q41745436)

8 October 2017

MRI pattern in asymptomatic natalizumab-associated PML. (English)

1 reference

8 October 2017

13

Frederik Barkhof

1 reference

8 October 2017

5

Joep Killestein

1 reference

8 October 2017

Mike P Wattjes

1

1 reference

8 October 2017

Anke Vennegoor

2

1 reference

8 October 2017

Martijn D Steenwijk

3

1 reference

8 October 2017

Marlieke de Vos

4

1 reference

8 October 2017

Bob W van Oosten

6

1 reference

8 October 2017

Jop Mostert

7

1 reference

8 October 2017

Dorine A Siepman

8

1 reference

8 October 2017

Wiebe Moll

9

1 reference

8 October 2017

Alex E L van Golde

10

1 reference

8 October 2017

Stephan T F M Frequin

11

1 reference

8 October 2017

Nancy D Richert

12

1 reference

8 October 2017

language of work or name

English

0 references

publication date

9 September 2014

1 reference

Journal of Neurology, Neurosurgery and Psychiatry

8 October 2017

1 reference

8 October 2017

86

1 reference

8 October 2017

7

1 reference

8 October 2017

793-798

1 reference

Natalizumab: bench to bedside and beyond

8 October 2017

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308630

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308630

Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308630

Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308630

PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308630

Case definition for progressive multifocal leukoencephalopathy following treatment with monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308630

Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308630

The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308630

Diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy using MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308630

MRI preclinical detection and asymptomatic course of a progressive multifocal leucoencephalopathy (PML) under natalizumab therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308630

Presymptomatic diagnosis with MRI and adequate treatment ameliorate the outcome after natalizumab-associated progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308630

Clinically silent PML and prolonged immune reconstitution inflammatory syndrome in a patient with multiple sclerosis treated with natalizumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308630

Asymptomatic progressive multifocal leukoencephalopathy associated with natalizumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308630

Unusual natalizumab-associated progressive multifocal leukoencephalopathy starting in the brainstem.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308630

Diagnosis of asymptomatic natalizumab-associated PML: are we between a rock and a hard place?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308630

A global optimisation method for robust affine registration of brain images

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308630

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308630

Progressive multifocal leukoencephalopathy after natalizumab monotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308630

Presumptive progressive multifocal leukoencephalopathy in multiple sclerosis after natalizumab therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308630

Progressive multifocal leukoencephalopathy revisited: Has the disease outgrown its name?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308630

Progressive multifocal leukoencephalopathy: why gray and white matter

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308630

JC virus granule cell neuronopathy: A novel clinical syndrome distinct from progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308630

Frequent infection of cortical neurons by JC virus in patients with progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308630

Fulminant JC virus encephalopathy with productive infection of cortical pyramidal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308630

JC virus granule cell neuronopathy and GCN-IRIS under natalizumab treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308630

Punctate lesion pattern suggestive of perivascular inflammation in acute natalizumab-associated progressive multifocal leukoencephalopathy: productive JC virus infection or preclinical PML-IRIS manifestation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308630

Progressive multifocal leukoencephalopathy: diffusion-weighted imaging and pathological correlations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308630

Progressive multifocal leukoencephalopathy after natalizumab discontinuation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308630

Cerebrospinal fluid JC virus antibody index for diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-308630

21 January 2018

Identifiers

DOI

10.1136/JNNP-2014-308630

1 reference

8 October 2017

1 reference